Publication

Antiangiogenic drugs in ovarian cancer.

Kumaran, Gireesh C
; ; 
Clamp, Andrew R
Citations
Altmetric:
Abstract
Ovarian cancer continues to be a major cause of morbidity and mortality in women. Antiangiogenic treatments have emerged as a promising strategy to treat ovarian cancer. This article reviews the rationale supporting the use of antiangiogenic treatments in ovarian cancer, the clinical development of this group of drugs and the toxicities specific to this modality of treatment.
Authors
Kumaran, Gireesh C
Jayson, Gordon C
Clamp, Andrew R
Affiliation
Department of Medical Oncology, Cancer Research UK, Manchester, UK. gkumaran@picr.man.ac.uk
Description
Date
2009-01-13
Publisher
Collections
All Paterson Institute for Cancer Research
Medical Oncology
Show all metadata
Keywords
Ovarian Cancer
Biomarkers
Adverse Effects
Type
Article
Citation
Antiangiogenic drugs in ovarian cancer. 2009, 100 (1):1-7 Br. J. Cancer
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/66157
Embedded videos